Binding and orientation of tricyclic antidepressants within the central substrate site of the human serotonin transporter.
about
Monoamine transporters: insights from molecular dynamics simulationsInsights to ligand binding to the monoamine transporters-from homology modeling to LeuBAT and dDATDesigning modulators of monoamine transporters using virtual screening techniquesA conserved leucine occupies the empty substrate site of LeuT in the Na(+)-free return state.Structures of LeuT in bicelles define conformation and substrate binding in a membrane-like contextStructural basis for action by diverse antidepressants on biogenic amine transportersLigand induced conformational changes of the human serotonin transporter revealed by molecular dynamics simulationsMapping Cholesterol Interaction Sites on Serotonin Transporter through Coarse-Grained Molecular DynamicsExploring the Inhibitory Mechanism of Approved Selective Norepinephrine Reuptake Inhibitors and Reboxetine Enantiomers by Molecular Dynamics StudyA conserved salt bridge between transmembrane segments 1 and 10 constitutes an extracellular gate in the dopamine transporterUnbiased simulations reveal the inward-facing conformation of the human serotonin transporter and Na(+) ion release.Structure-activity relationships for a novel series of citalopram (1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile) analogues at monoamine transportersDiscovery of novel-scaffold monoamine transporter ligands via in silico screening with the S1 pocket of the serotonin transporterMolecular determinants for selective recognition of antidepressants in the human serotonin and norepinephrine transporters.Properties of an inward-facing state of LeuT: conformational stability and substrate release.Identification of a novel selective serotonin reuptake inhibitor by coupling monoamine transporter-based virtual screening and rational molecular hybridizationProbing binding pocket of serotonin transporter by single molecular force spectroscopy on living cells.Azidobupramine, an Antidepressant-Derived Bifunctional Neurotransmitter Transporter Ligand Allowing Covalent Labeling and Attachment of Fluorophores.Molecular mechanism of serotonin transporter inhibition elucidated by a new flexible docking protocol.Binding of the amphetamine-like 1-phenyl-piperazine to monoamine transporters.The solute carrier 6 family of transportersSteric hindrance mutagenesis in the conserved extracellular vestibule impedes allosteric binding of antidepressants to the serotonin transporterMechanism of Paroxetine (Paxil) Inhibition of the Serotonin Transporter.Genetically encoded photocrosslinkers locate the high-affinity binding site of antidepressant drugs in the human serotonin transporter.The binding sites for benztropines and dopamine in the dopamine transporter overlap.Nanopharmacological Force Sensing to Reveal Allosteric Coupling in Transporter Binding SitesDesign and synthesis of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile (citalopram) analogues as novel probes for the serotonin transporter S1 and S2 binding sites.Identification of novel serotonin transporter compounds by virtual screening.Binding-induced fluorescence of serotonin transporter ligands: A spectroscopic and structural study of 4-(4-(dimethylamino)phenyl)-1-methylpyridinium (APP(+)) and APP(+) analogues.Substrate and drug binding sites in LeuT.Vesicular and plasma membrane transporters for neurotransmitters.Computational methods for the discovery of mood disorder therapies.Structure-activity relationship studies of citalopram derivatives: examining substituents conferring selectivity for the allosteric site in the 5-HT transporterComparative modeling of the human monoamine transporters: similarities in substrate binding.(S)- and (R)-fluoxetine as native markers in mass spectrometry (MS) binding assays addressing the serotonin transporter.Binding site residues control inhibitor selectivity in the human norepinephrine transporter but not in the human dopamine transporterImportance of the Extracellular Loop 4 in the Human Serotonin Transporter for Inhibitor Binding and Substrate Translocation.Substrate binding and translocation of the serotonin transporter studied by docking and molecular dynamics simulations.Interaction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket.A dualistic conformational response to substrate binding in the human serotonin transporter reveals a high affinity state for serotonin.
P2860
Q26777242-D31D4838-4BC5-4567-BDE7-E57450035D20Q26781554-9EAC384B-1627-4BA7-B0F5-C7781153D0D4Q26781605-6E200D8A-269C-45A2-9495-7D9DA2CADF80Q27315933-6C339F05-0B13-4581-A467-60084A21BC39Q27676749-9670782E-35B7-4CF7-9081-4A8019CFB384Q27680298-074A1CF7-BA79-4EA6-9581-2DF33643B1C8Q28533835-83448107-0A9F-4F7E-82F6-2F29D9604D6BQ28554731-4068FEF0-901E-45CB-ACF5-D279D13C60F4Q28833274-D75D47DE-6E4F-4C72-A27B-DD091B4E1157Q30368030-83D1EED9-3596-4AD6-95DC-20BB1299193BQ34064167-D580F335-F478-40F7-9CDA-979209BD5807Q34102188-D755E2B8-8009-488C-B94D-190A4567447AQ34249476-0E2580F4-E18C-4E2E-95FD-7682A705D270Q35123142-72D6EBEE-1B58-466A-83FD-D763383CB8C1Q35222032-A27963F5-4032-4C16-B95F-C62CD4A33A1DQ35234897-FD861366-62E1-452B-966D-55F183828A5FQ35643579-2303D915-2DFC-4EAC-B450-C51193249EF3Q35919818-0F410FC4-60EE-4CF8-9461-6124431DBDF0Q35975646-35D2E626-578E-4A3A-AD22-4106771E8950Q36248541-5A2E412A-062A-4D9E-8C74-97388A3572FFQ36346899-F7EA3746-B3CC-4EA6-9423-D1322C7C1FDEQ36407799-A3F3709D-C0F3-41CE-9B4E-A8FCAA052F23Q36754967-2D160AEE-91F8-4D31-B203-0A6C0E590175Q36819600-69632B42-8EC7-44AC-AE91-6F719C1B5057Q36990361-265C11E1-A72F-4B85-A491-42EE16EECE45Q37064777-A2966AC5-B76D-4F87-9BEB-64A957D9BD48Q37490255-FE620BB8-2ECE-4761-9290-E00F6AC6E3C2Q37695877-ECF15B50-725C-46A8-86D8-07991700E189Q37709391-33F027A7-81CF-46DF-B2BD-CC54C4468003Q37782457-CDB51F84-33B4-4C49-8840-D97D6857C471Q37971367-D2FD8189-DE34-410C-B6F3-4AA2A8E96063Q38014572-5A7F7942-562F-47ED-8EA4-4C1BCAFAF08AQ38572969-EB8B6A31-4E28-4B82-B5D5-F2815D74E0D6Q39192034-625A9D3C-CABB-4EBA-B3D3-9073D445E745Q39500111-C0221B32-F16A-4B3E-A645-FA766377AECDQ40390385-AA90B64F-69F7-453E-950C-167478788384Q41027994-6D13186C-3EA8-4FFF-9F28-FCBF60B998A6Q41380700-966832C6-5D51-47F8-B567-96BDC4275325Q42425044-AAD01849-0B74-4917-A315-FE4B2B5E8267Q43195423-0E70F326-1EFF-41EE-A22D-9AD4E16048B2
P2860
Binding and orientation of tricyclic antidepressants within the central substrate site of the human serotonin transporter.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Binding and orientation of tri ...... e human serotonin transporter.
@ast
Binding and orientation of tri ...... e human serotonin transporter.
@en
type
label
Binding and orientation of tri ...... e human serotonin transporter.
@ast
Binding and orientation of tri ...... e human serotonin transporter.
@en
prefLabel
Binding and orientation of tri ...... e human serotonin transporter.
@ast
Binding and orientation of tri ...... e human serotonin transporter.
@en
P2093
P2860
P50
P356
P1476
Binding and orientation of tri ...... he human serotonin transporter
@en
P2093
Heidi Koldsø
Henrik Helligsø Jensen
Kasper Severinsen
Leyla Celik
Marie Jensen
Mikael Bols
Ove Wiborg
Tine Meyer
P2860
P304
P356
10.1074/JBC.M109.045401
P407
P577
2009-11-30T00:00:00Z